#RSAC: CISA Outlines Bad Practices Every Organization Should Avoid
Some IT practices are more dangerous than others, according to CISA
Stay informed on the latest CISA updates, guidelines, and alerts critical for robust information security and cyber threat prevention.
Search across headline titles and summaries.
Background for this topic.
Cybersecurity and Infrastructure Security Agency (CISA) is the U.S. Department of Homeland Security agency for reducing cyber and physical risks to critical infrastructure and federal civilian networks. Created by the 2018 CISA Act, it works with government and industry, publishes alerts and guidance, and coordinates assistance during significant incidents. Its direct federal-network role chiefly covers the Federal Civilian Executive Branch, including .gov; private-sector engagement is often voluntary or sector-specific.
Practitioners use CISA advisories and the Known Exploited Vulnerabilities catalog to prioritize patching where exploitation has been observed, and consult applicable directives and incident-response guidance. CISA supports vulnerability reporting and promotes controls such as multifactor authentication, logging, and tested recovery. A CISA alert is an actionable risk signal, not proof every organization is affected; teams should verify product, version, exposure, and obligations.
Some IT practices are more dangerous than others, according to CISA
CISA published a new advisory warning organizations about China-based, state-sponsored cyber-attacks
NSA, FBI and CISA issue joint advisory that suggests China hardly has to work for this – flaws revealed in 2017 are among their entry points State-sponsored Chinese attackers are actively exploiting old vulnerabilities to "establish a broad network of compromised infrastructure" then using it to attack telcos and network services providers.…
Nation’s cyber defense agency urges America to enable multifactor authentication.
The U.S. Cybersecurity and Infrastructure Security Agency (CISA) and Food and Drug Administration (FDA) have issued an advisory about critical security vulnerabilities in Illumina's next-generation sequencing (NGS) software